Solid Biosciences (SLDB) EPS (Basic): 2017-2024
Historic EPS (Basic) for Solid Biosciences (SLDB) over the last 7 years, with Dec 2024 value amounting to -$1.02.
- Solid Biosciences' EPS (Basic) fell 2.00% to -$1.02 in Q4 2024 from the same period last year, while for Dec 2024 it was -$3.06, marking a year-over-year increase of 36.78%. This contributed to the annual value of -$3.06 for FY2024, which is 36.65% up from last year.
- Per Solid Biosciences' latest filing, its EPS (Basic) stood at -$1.02 for Q4 2024, which was down 29.11% from -$0.79 recorded in Q3 2024.
- Solid Biosciences' EPS (Basic)'s 5-year high stood at -$0.31 during Q4 2020, with a 5-year trough of -$3.38 in Q2 2022.
- In the last 3 years, Solid Biosciences' EPS (Basic) had a median value of -$1.02 in 2024 and averaged -$1.33.
- Examining YoY changes over the last 5 years, Solid Biosciences' EPS (Basic) showed a top increase of 63.02% in 2023 and a maximum decrease of 47.06% in 2023.
- Quarterly analysis of 4 years shows Solid Biosciences' EPS (Basic) stood at -$0.31 in 2020, then reached -$0.68 in 2022, then tumbled by 47.06% to -$1 in 2023, then fell by 2.00% to -$1.02 in 2024.
- Its EPS (Basic) stands at -$1.02 for Q4 2024, versus -$0.79 for Q3 2024 and -$0.61 for Q2 2024.